<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0202221673
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CAVERJECT 20MCG VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALPROSTADIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        µg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder and solvent for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        44.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C01EA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        G04BE01
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Caverject belongs to the group of natural fatty acids. Alprostadil normally produced by the body is called prostaglandin E. This substance causes widening of the blood vessels and mild inhibition of blood coagulation, among other effects. After injecting Caverject into the corpus cavernosum of the penis (similar to reservoirs in the penis, which fill with blood on sexual arousal, causing the penis to swell), it will cause an erection.</p><p>&nbsp;</p><p>Caverject is indicated for:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; the treatment of erectile dysfunction caused by a problem in the nervous or circulatory system, or of psychological origin. The cause may also be a mixture of these.<strong> </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; the diagnosis of erectile dysfunction.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Caverject:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to alprostadil or any of the other ingredients of this medicine listed in section 6.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are prone to prolonged erections following a disease of the red blood cells known as sickle cell anaemia, latent sickle cell disease (without anaemia), or blood cancer (leukaemia or multiple myeloma).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have certain abnormalities of the penis such as angulation of the penis, phimosis (tight foreskin), cavernous fibrosis (loss of elasticity in the corpus cavernosum, preventing it from swelling) or Peyronie&rsquo;s disease (benign sclerosis of the corpus cavernosum, causing a curve in the penis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you wear a penile implant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If sexual activity is not advisable.</p><p>&nbsp;</p><p>Caverject should not be given to children or infants.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before using Caverject.</p><p>Before starting treatment with Caverject, your doctor will determine the underlying treatable medical cause of the erection disorder and will treat this if possible.&nbsp;&nbsp;<br />&nbsp;</p><p><u>Persistent erection (priapism)</u></p><p>Injecting Caverject may cause a prolonged erection. Tell your doctor immediately if an erection lasts longer than 4 hours, which must be treated within 6 hours. To minimise the risk, choose the lowest effective dose (see also section 3, &ldquo;If you use more Caverject than you should&rdquo;). Before starting treatment with Caverject, your doctor will tell you what to do if this happens.</p><p>&nbsp;</p><p><u>Anatomical deformation of the penis (penile fibrosis)</u></p><p>If you have an anatomical penis abnormality (angulation, phimosis, cavernous fibrosis, Peyronie&rsquo;s disease or plaques), you may experience pain when you get an erection.</p><p>&nbsp;</p><p>Regular monitoring and careful examination of the penis are recommended in order to identify any changes to the internal structure of the penis early on. Penile fibrosis, possibly with angulation, cavernous fibrosis, fibrotic nodules or Peyronie&rsquo;s disease may occur following intracavernosal administration of Caverject. Fibrosis may increase in cases of prolonged use. Treatment with Caverject should be discontinued if changes can be seen in the shape or induration (hardened areas of the penis) occurs.</p><p>&nbsp;</p><p><u>Sexually transmitted diseases and blood-borne diseases, including HIV</u></p><p>Caverject does not protect you from sexually transmitted diseases after being injected into the corpus cavernosum of the penis. Use suitable methods of contraception to protect you from sexually transmitted diseases such as HIV/AIDS. Injecting Caverject may cause slight bleeding at the injection site (see section 4, &ldquo;Possible side effects&rdquo;), which increases the risk of contamination.</p><p>&nbsp;</p><p>Take special care:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking anticoagulants (e.g. warfarin or heparin), the risk of bleeding may increase after injection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have had a transient ischaemic attack (stroke with complete recovery) or if you have an unstable heart condition, you should use Caverject with caution.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have one or more risk factors for stroke (these can include high blood pressure, high cholesterol, coronary artery disease, cardiac arrhythmia, diabetes).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are already taking a medicine for erectile dysfunction: Caverject may not be injected at the same time as any other medicine used to treat erectile dysfunction.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a history of mental illness or addiction, as you might be more prone to abusing Caverject.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have heart disease, a lung disease or heart failure. In these cases, arousal or sexual activity may cause heart or lung problems. You should therefore use Caverject with caution and be careful when engaging in sexual activity.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have one or more cardiovascular risk factors (these can include high blood pressure, smoking, high blood sugar, high cholesterol, being overweight and obesity).</p><p>&nbsp;</p><p>This medicine has been prescribed for you as part of a specific course of medical treatment. It must not be used by others, nor to treat any other symptoms.</p><p>&nbsp;</p><p><u>Needle breakage</u></p><p>The needle used to administer Caverject is very fine. Like all very fine needles, it can break.</p><p>&nbsp;</p><p>Cases of needle breakage have been reported, with part of the needle remaining in the penis. In some cases, hospitalisation and an operation to remove it have been necessary.</p><p>&nbsp;</p><p>Specific instructions on proper handling and injection techniques can reduce the risk of breaking the needle (see also section 3, &ldquo;How to use Caverject&rdquo;).</p><p>&nbsp;</p><p><strong>Other medicines and Caverject</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for erectile dysfunction: do not use other medicines to treat erectile dysfunction (e.g. sildenafil) or other medicines that could cause an erection (e.g. papaverine) at the same time as using Caverject, as this would increase the risk of prolonged erection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for the nervous system: sympathomimetics (medicines that stimulate certain parts of the nervous system) may diminish the effect of Caverject.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for the cardiovascular system: Caverject may increase the effects of antihypertensives (medicines used to reduce high blood pressure), vasodilators (medicines used to widen the blood vessels) and inhibitors of blood coagulation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anticoagulants: if you are taking anticoagulants (inhibitors of platelet aggregation, e.g. warfarin or heparin), the risk of bleeding may increase.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>There are no known effects on your fertility.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Alprostadil should not affect your ability to drive or use machines.</p><p><strong>&nbsp;</strong></p><p><strong>Caverject solvent contains benzyl alcohol and sodium</strong></p><p>This medicine contains benzyl alcohol.</p><p>&nbsp;</p><p>Benzyl alcohol can cause allergic reactions.</p><p>&nbsp;</p><p>The use of large amounts of Caverject powder and solvent for solution for injection can cause a build-up of benzyl alcohol in your body resulting in an increase in acid levels in your blood (called &ldquo;metabolic acidosis&rdquo;). Patients with liver or kidney disease should be particularly careful and consult their doctor or pharmacist.</p><p>&nbsp;</p><p>Benzyl alcohol has been associated with the risk of severe side effects including breathing problems (called &ldquo;gasping syndrome&rdquo;) in young children. Caverject powder and solvent for solution for injection should not be used in children.</p><p>&nbsp;</p><p>This medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. it is essentially &ldquo;sodium-free&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>Your doctor will decide how much Caverject you should inject. This will depend on what is causing your erectile dysfunction. It is therefore very important that you follow the recommendations of your doctor closely.</p><p>&nbsp;</p><p>Your doctor will administer the injection the first time, and will show you how to administer the injections yourself, if this is set out in your treatment plan.</p><p>The product is intended for single use only. The syringe and any unused solution should be disposed of appropriately (see step 6 of the injection protocol below).</p><p><br />Your doctor will advise on the best dose for you. Normally, the starting dose is 1.25 to 2.5 micrograms. The dose will then be increased in increments until a dose is reached that enables you to have an erection strong enough for sexual activity, but which does not cause an erection that lasts longer than an hour. If you experience a prolonged erection, consult your doctor. Erection normally occurs 10 to 30 minutes after the injection.</p><p>&nbsp;</p><p>The optimal dose is usually between 1.25 micrograms and 20 micrograms per injection. No more than 60 micrograms should be administered per injection. Caverject should not be used more than once per day or more than three times per week.</p><p>You should consult your doctor every 3 to 4 months. The dose can be adjusted gradually, if required or advised, but always consult your doctor first.<br />&nbsp;</p><p>Always use this medicine exactly as your doctor has told you.</p><p>Consult your doctor or pharmacist if you have any questions about using this medicine.</p><p>&nbsp;</p><p>PREPARING THE SOLUTION</p><p>The solution must be prepared under sterile conditions. When preparing the solution, follow the advice given to you by your doctor and follow the instructions below.</p><p>1.&nbsp;&nbsp;&nbsp; Wash your hands and dry them with a clean towel.</p><p>2.&nbsp;&nbsp;&nbsp; Remove the plastic cap covering the stopper of the vial containing the powder. The stopper must always stay on the vial. Disinfect the top part of the stopper using one of the two alcohol swabs, then dispose of the swab.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1033" type="#_x0000_t75" style='width:126.4pt;
 height:81.75pt;visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
 o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.emz"
  o:title=""/>
 <w:bordertop type="single" width="4"/>
 <w:borderleft type="single" width="4"/>
 <w:borderbottom type="single" width="4"/>
 <w:borderright type="single" width="4"/>
</v:shape><![endif]--><img width="170" height="110" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image002.gif" /></p><p>Disinfect the stopper</p><p>&nbsp;</p><p>3.&nbsp;&nbsp;&nbsp; Depending on how the medicine is supplied, continue as follows:</p><p><u>&nbsp;</u></p><p><u>Caverject vial of powder + ampoule of solvent</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Open the ampoule containing the solvent by pushing on the part shown in the diagram, with the tip facing you.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape id="Picture_x0020_1" o:spid="_x0000_i1032"
 type="#_x0000_t75" alt="Caverject_fig2" style='width:236.25pt;height:79.9pt;
 visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
 o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image003.jpg"
  o:title="Caverject_fig2" croptop="4141f" cropbottom="12621f" cropleft="1634f"
  cropright="1729f"/>
 <w:bordertop type="single" width="4"/>
 <w:borderleft type="single" width="4"/>
 <w:borderbottom type="single" width="4"/>
 <w:borderright type="single" width="4"/>
</v:shape><![endif]--><img width="316" height="108" alt="Caverject_fig2" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image004.jpg" /></p><p>&nbsp;&nbsp; &nbsp;&nbsp;Open the ampoule&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Place the open ampoule on a clean surface.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Attach the long needle (22 G 1 1/2 inch) to the tip of the syringe and remove the protective cover.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Pull the plunger to draw all the contents (1 ml) of the ampoule into the syringe.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape id="Picture_x0020_4" o:spid="_x0000_i1031"
 type="#_x0000_t75" alt="Caverject_fig3" style='width:252.75pt;height:73.9pt;
 visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
 o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image005.jpg"
  o:title="Caverject_fig3" croptop="5749f" cropbottom="11785f" cropleft="2238f"
  cropright="2557f"/>
 <w:bordertop type="single" width="4"/>
 <w:borderleft type="single" width="4"/>
 <w:borderbottom type="single" width="4"/>
 <w:borderright type="single" width="4"/>
</v:shape><![endif]--><img width="338" height="100" alt="Caverject_fig3" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image006.jpg" /></p><p>&nbsp;&nbsp;&nbsp;&nbsp; Attach the long needle to the syringe and remove the protective cover.</p><p><u>&nbsp;</u></p><p>4.&nbsp;&nbsp;&nbsp; Push the needle through the rubber vial stopper, which has already been disinfected. Empty all the contents of the syringe into the vial containing the powder.</p><p>5.&nbsp;&nbsp;&nbsp; Gently shake the vial (without removing the syringe) until the powder has completely dissolved.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape
 id="Picture_x0020_5" o:spid="_x0000_i1030" type="#_x0000_t75" style='width:130.5pt;
 height:83.65pt;visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
 o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image007.emz"
  o:title=""/>
 <w:bordertop type="single" width="2"/>
 <w:borderleft type="single" width="2"/>
 <w:borderbottom type="single" width="2"/>
 <w:borderright type="single" width="2"/>
</v:shape><![endif]--><img width="175" height="113" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image008.gif" /></p><p>Add the solvent to the contents of the vial and shake until the solvent has completely dissolved</p><p>&nbsp;</p><p>The solution is now ready to be injected. It contains 20 micrograms of alprostadil per ml. Do not add any other products to the solution. The solution should be clear and colourless. If not, do not use it. When stored in the original vial, the reconstituted solution is stable at (2 &deg;C &ndash; 8 &deg;C) for 24 hours. It must not be frozen.</p><p>&nbsp;</p><p>INJECTING THE SOLUTION INTO THE PENIS</p><p>The first injection will be administered by your doctor, who will show you how to inject the product yourself. Follow their instructions closely when you are injecting the Caverject yourself. You can follow the step-by-step instructions shown below.</p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp; Draw the amount of solution you have been prescribed into the syringe.</p><p>2.&nbsp;&nbsp;&nbsp; Remove the needle from the syringe (the needle stays in the vial).</p><p>3.&nbsp;&nbsp;&nbsp; Attach the injection needle (short needle, 30 G 1/2 inch) to the tip of the syringe and remove the protective cover.</p><p>4.&nbsp;&nbsp;&nbsp; If the needle is bent, do not use it. Do not try to straighten a bent needle. Remove the needle from the syringe, throw it away and attach a new unused and sterile injection needle to the syringe.</p><p>5.&nbsp;&nbsp;&nbsp; Holding the syringe with the needle pointing upwards, push the plunger down gradually until a drop appears at the tip of the injection needle. Place the syringe on a hard, flat surface, ensuring that nothing touches the injection needle.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape id="Picture_x0020_14" o:spid="_x0000_i1029"
 type="#_x0000_t75" style='width:79.9pt;height:88.5pt;visibility:visible;
 mso-wrap-style:square' o:bordertopcolor="black" o:borderleftcolor="black"
 o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image009.emz"
  o:title=""/>
 <w:bordertop type="single" width="2"/>
 <w:borderleft type="single" width="2"/>
 <w:borderbottom type="single" width="2"/>
 <w:borderright type="single" width="2"/>
</v:shape><![endif]--><img width="108" height="119" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image010.gif" />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[if gte vml 1]><v:shape
 id="Picture_x0020_17" o:spid="_x0000_i1028" type="#_x0000_t75" style='width:119.65pt;
 height:86.65pt;visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
 o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image011.emz"
  o:title=""/>
 <w:bordertop type="single" width="2"/>
 <w:borderleft type="single" width="2"/>
 <w:borderbottom type="single" width="2"/>
 <w:borderright type="single" width="2"/>
</v:shape><![endif]--><img width="161" height="117" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image012.gif" /></p><p>Draw the solution&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove any air bubbles</p><p>into the syringe</p><p>&nbsp;</p><p>6.&nbsp;&nbsp;&nbsp; The injection itself</p><p>-&nbsp;&nbsp; Sit comfortably.</p><p>-&nbsp;&nbsp; If you are right-handed, take hold of your penis with your left hand, just behind the head of the penis. If you are not circumcised, make sure your foreskin is pulled back as far as possible from the head of the penis. Hold the penis towards your left thigh. On the outer layer of the penis, you will notice an area that bulges out towards the left when you squeeze it. This is one of the two corpora cavernosa. This is where you should inject the solution (shaded areas in the diagram).</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:655px"><tbody><tr><td style="vertical-align:top"><p><!--[if gte vml 1]><v:shape
   id="Picture_x0020_21" o:spid="_x0000_i1027" type="#_x0000_t75" style='width:108pt;
   height:89.65pt;visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
   o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
   <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image013.png"
    o:title="" cropleft="4936f" cropright="7352f"/>
   <w:bordertop type="single" width="2"/>
   <w:borderleft type="single" width="2"/>
   <w:borderbottom type="single" width="2"/>
   <w:borderright type="single" width="2"/>
  </v:shape><![endif]--><img width="145" height="121" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image014.jpg" /></p><p>Injection areas</p></td><td style="vertical-align:top"><p><!--[if gte vml 1]><v:shape
   id="Picture_x0020_19" o:spid="_x0000_i1026" type="#_x0000_t75" style='width:128.25pt;
   height:88.5pt;visibility:visible;mso-wrap-style:square' o:bordertopcolor="black"
   o:borderleftcolor="black" o:borderbottomcolor="black" o:borderrightcolor="black">
   <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image015.emz"
    o:title=""/>
   <w:bordertop type="single" width="2"/>
   <w:borderleft type="single" width="2"/>
   <w:borderbottom type="single" width="2"/>
   <w:borderright type="single" width="2"/>
  </v:shape><![endif]--><img width="172" height="119" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image016.gif" /></p><p>Cross-section of the penis</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>Veins &ndash; nerves</p><p>Insert the needle at a 90&deg; angle</p><p>Corpus cavernosum</p><p>Urethra</p></td></tr></tbody></table><p>&nbsp;</p><p>-&nbsp;&nbsp; With the second alcohol swab, use your right hand to disinfect the skin covering the corpus cavernosum into which you are going to inject the solution. Leave it to dry for a few seconds.</p><p>-&nbsp;&nbsp; With your left hand, keep your penis extended during the injection. With your right hand, insert the needle through the skin at a 90&deg; angle, until you reach the corpus cavernosum. Avoid the blood vessels on the surface and other visible structures.</p><p>-&nbsp;&nbsp; Inject the entire contents of the syringe. If you are unable to do so, remove the needle slightly and start again.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape id="Picture_x0020_20" o:spid="_x0000_i1025"
 type="#_x0000_t75" style='width:120.75pt;height:75.75pt;visibility:visible;
 mso-wrap-style:square' o:bordertopcolor="black" o:borderleftcolor="black"
 o:borderbottomcolor="black" o:borderrightcolor="black">
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image017.emz"
  o:title=""/>
 <w:bordertop type="single" width="2"/>
 <w:borderleft type="single" width="2"/>
 <w:borderbottom type="single" width="2"/>
 <w:borderright type="single" width="2"/>
</v:shape><![endif]--><img width="162" height="102" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image018.gif" /></p><p>&nbsp;&nbsp;&nbsp;&nbsp; Insert the needle and inject</p><p>&nbsp;</p><p>-&nbsp;&nbsp; Remove the needle and press the cleansing swab onto the injection site. Massage the penis to allow the product to spread.</p><p>-&nbsp;&nbsp; You should change the injection site regularly, as your doctor has shown you.</p><p>7.&nbsp;&nbsp;&nbsp; The solution is for single use. Do not keep any remaining solution. If you are using Caverject vial of powder + ampoule, carefully wrap the used needles before disposing of them along with the vial and the syringe.</p><p><strong>&nbsp;</strong></p><p><strong>If you use more Caverject than you should</strong></p><p>If you have used or taken too much Caverject, immediately contact your doctor, pharmacist or the poison control centre.</p><p>&nbsp;</p><p><strong>If you forget to use Caverject</strong></p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop using Caverject</strong></p><p>Always consult your doctor if you are considering stopping treatment.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>The most common side effect after injection is mild to moderate pain in the penis, reported at least once by almost one third of patients.</p><p>Penile fibrosis is also a fairly common side effect, which can cause deformation or induration (angulation, fibrotic nodules and Peyronie&#39;s disease).</p><p>In some patients, haematoma may occur at the injection site, which is related more to the injection technique rather than to the medicine itself.</p><p>After injecting Caverject, an erection lasting for 4 to 6 hours may occur. It is very rare for an erection to last longer than 6 hours. If an erection lasts longer than 4 hours, consult your doctor.</p><p>&nbsp;</p><p>The following side effects have been reported:</p><p>&nbsp;</p><p><strong>Very common side effects </strong>(may affect more than 1 in 10 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; pain in the penis</p><p>&nbsp;</p><p><strong>Common side effects </strong>(may affect up to 1 in 10 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; prolonged erection, deformation or induration of the penis, other problems with the penis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; redness of the skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; haematoma, haematoma at the injection site, bruising</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; muscle spasms (cramps)</p><p>&nbsp;</p><p><strong>Uncommon side effects </strong>(may affect up to 1 in 100 people):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; infections: fungal infections, colds</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; fainting, loss of sensitivity, increased sensitivity, headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; dilated pupils</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; heart rhythm disorders (supraventricular extrasystoles)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; venous problems, hypotension (low blood pressure), vasodilation and blood vessel problems, bleeding from veins</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; nausea, dry mouth</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; excessive sweating, skin rash, itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; pain in the hips or back, weak gluteal muscles, pain in the buttocks, legs or abdomen</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; difficulty urinating, blood in the urine, increased urinary frequency, urinary urgency and incontinence, bleeding from the urethra (the duct through which urine passes through the penis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; erection problems, ejaculatory disorders, inflammation of the head of the penis (balanitis), painful erection, phimosis (narrowing of the foreskin), priapism (prolonged erection), pain in the testes, scrotal disorders (pouch of skin containing the testes), redness of the scrotum, pain in the scrotum, fluid retention in the scrotum (oedema), benign cyst (spermatocele) in the tube carrying sperm out from the testes, testicular disorders, testicular swelling, fluid retention in the testes, lump on the testes, pain in the lower abdomen (pelvic region)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; general weakness, bleeding (haemorrhage), inflammation, peripheral oedema (fluid retention affecting the face and limbs, particularly the legs), oedema, pain or sensation of pressure, flu-like syndrome</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; problems at the injection site: bleeding, inflammation, itching, swelling, oedema, warm sensation, irritation, loss of feeling (anaesthesia), pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; decrease in blood pressure, increase in heart rate, increase in the amount of creatinine in the blood (observed during a blood test)</p><p>&nbsp;</p><p><strong>Frequency not known </strong>(cannot be estimated from the available data):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; lack of blood flow to the heart muscle through the coronary arteries</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; stroke</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via national reporting system.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>To report side effects:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>- The National Pharmacovigilance Centre (NPC)</p>&nbsp;<p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa/ &nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other </strong><strong>GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Store below 30 &deg;C.</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the carton after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Shelf life: 3 years.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is alprostadil:</p><p>each vial of powder contains 20 micrograms alprostadil.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are:</p><p>- powder: lactose monohydrate, sodium citrate, dilute hydrochloric acid, sodium hydroxide.</p><p>- solvent: benzyl alcohol, (see section&nbsp;2 &ldquo;Caverject solvent contains benzyl alcohol and sodium&rdquo;), water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Solution for injection, obtained from mixing the powder and the solvent, both of which are enclosed.
	
Pack sizes:
Caverject 20 micrograms, powder and solvent for solution for injection: 1 vial of powder + 1 ampoule of 1 ml solvent 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><em>Marketing Authorisation Holder:</em></p><p>Pfizer SA, Belgium.</p><p>&nbsp;</p><p><em>Manufacturer</em>:</p><p>Pfizer Manufacturing Belgium NV, Belgium.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October 2023. 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي كافيرجيكت إلى مجموعة الأحماض الدهنية الطبيعية. تُعرف مادة ألبروستاديل التي ينتجها الجسم بشكل طبيعي باسم بروستاجلاندين E. وتسبب هذه المادة، من بين آثار أخرى، اتساع الأوعية الدموية وتثبيط خفيف لتجلط الدم. بعد حقن كافيرجيكت في الجسم الكهفي للقضيب أو العضو الذكري (يشبه مستودعات موجودة بالقضيب تمتلئ بالدم عند الإثارة الجنسية، مما يسبب امتلاء جسم القضيب) فإنه سيسبب حدوث انتصاب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">دواعي استعمال كافيرجيكت:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; علاج خلل الانتصاب الوظيفي الذي تسببه مشكلة بالجهاز العصبي أو الدورة الدموية أو الذي يرجع إلى أصل نفسي. وقد يكون السبب أيضًا خليط من هذه الأمور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تشخيص الحالة بخلل الانتصاب الوظيفي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>موانع استعمال كافيرجيكت </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه ألبروستاديل أو أي مكون آخر من مكونات هذا الدواء المدرجة في القسم ٦.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت عرضة للإصابة بالانتصاب المطول بعد إصابتك بمرض في خلايا الدم الحمراء يُعرف بفقر الدم المنجلي، أو مرض الخلايا المنجلية الكامن (دون فقر دم) أو سرطان الدم (ابيضاض الدم أو الورم النقوي المتعدد).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا ببعض الاضطرابات في القضيب (العضو الذكري) مثل تزوي القضيب؛ أو الشبم (تضيق القلفة)؛ أو التليف الكهفي (فقدان مرونة الجسم الكهفي، مما يمنع امتلائه)؛ أو مرض بيروني (تصلب حميد في الجسم الكهفي، مما يسبب انحناءً في القضيب).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك دعامة داخل القضيب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان النشاط الجنسي لا يُنصح به في حالتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ينبغي عدم إعطاء كافيرجيكت للأطفال أو الرضع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال كافيرجيكت</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل استخدام كافيرجيكت.</p><p dir="RTL">قبل بدء العلاج باستخدام كافيرجيكت، سيحدد طبيبك السبب الطبي الكامن القابل للعلاج وراء اضطرابات الانتصاب وسوف يقوم بعلاجه إن أمكن.<br />&nbsp;</p><p dir="RTL"><u>الانتصاب المستمر (القساح)</u></p><p dir="RTL">قد يسبب حقن كافيرجيكت انتصابًا مطولًا. أخبر طبيبك فورًا إذا استمر الانتصاب لأكثر من ٤ ساعات، وهو ما يجب علاجه خلال ٦ ساعات. لتقليل الخطر، اختر أقل جرعة فعالة (انظر أيضًا القسم ٣، &quot;في حالة استخدامك جرعة من كافيرجيكت أكبر مما ينبغي&quot;). وقبل بدء العلاج باستخدام كافيرجيكت، سيخبرك طبيبك بما عليك فعله إذا حدث ذلك.<br />&nbsp;</p><p dir="RTL"><u>التشوه التشريحي في القضيب (تليف القضيب)</u></p><p dir="RTL">في حالة كان لديك خلل تشريحي بالقضيب (تزوي، أو شبم، أو تليف كهفي، أو مرض بيروني، أو لويحات)، فقد تعاني من وجود ألم عند الانتصاب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يوصى بالمراقبة المنتظمة والفحص الدقيق للقضيب من أجل التعرف على أي تغيرات في التركيب الداخلي للقضيب مبكرًا. قد يحدث تليف بالقضيب، مصحوب بتزوي محتمل، أو تليف كهفي أو عقيدات تليفية أو مرض بيروني بعد استعمال كافيرجيكت داخل الجسم الكهفي. وقد يزداد التليف في حالة الاستخدام المطول. ينبغي إيقاف العلاج بكافيرجيكت في حالة ظهور تغيرات في شكل القضيب أو حدوث تيبس (وجود مناطق متصلبة في القضيب).<br />&nbsp;</p><p dir="RTL"><u>الأمراض المنقولة جنسيًا والأمراض التي تنتقل عبر الدم بما في ذلك فيروس نقص المناعة </u><u>ا</u><u>لبشرية (</u><u>HIV</u><u>)</u></p><p dir="RTL">لا يحميك كافيرجيكت من الأمراض المنقولة جنسيًا بعد حقنه في الجسم الكهفي بالقضيب. استخدم وسائل منع حمل مناسبة لحمايتك ضد الأمراض المنقولة جنسيًا مثل فيروس نقص المناعة المكتسبة البشري (HIV)/الإيدز. قد يتسبب حقن كافيرجيكت في حدوث نزيف بسيط في موضع الحقن (انظر القسم ٤ &quot;الآثار الجانبية المحتملة&quot;)، وهو ما يزيد من خطر حدوث التلوث.<br />&nbsp;</p><p dir="RTL">توخَ الحذر بشكلٍ خاص:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أدوية مضادة للتجلط (مثل وارفارين أو هيبارين)، فقد يزيد خطر النزيف بعد الحقن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا أصبت سابقًا بنوبة إقفارية عابرة (سكتة دماغية مع تعافٍ كامل)، أو إذا كنت تعاني من حالة قلبية غير مستقرة، ينبغي عليك حينها استخدام كافيرجيكت بحرص.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك عامل خطر واحد أو أكثر للإصابة بالسكتة الدماغية (قد تتضمن تلك العوامل ضغط الدم المرتفع، ارتفاع الكولستيرول، مرض الشريان التاجي، اضطراب ضربات القلب، داء السكري).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تأخذ بالفعل دواءً آخر لعلاج خلل الانتصاب الوظيفي: يجب عدم حقن كافيرجيكت بالتزامن مع أي دواء آخر مستخدم لعلاج خلل الانتصاب الوظيفي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ من الإصابة بأمراض عقلية أو إدمان، حيث قد تكون أكثر عرضة لسوء استخدام (معاقرة) كافيرجيكت.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض قلبي أو مرض رئوي أو فشل قلبي، ففي هذه الحالات قد تؤدي الإثارة أو النشاط الجنسي إلى حدوث مشكلات بالقلب أو الرئة. لذلك ينبغي عليك استخدام كافيرجيكت بحرص، وتوخي الحذر عند ممارسة النشاط الجنسي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك عامل خطر واحد أو أكثر للإصابة بالأمراض القلبية الوعائية (قد تتضمن تلك العوامل ضغط الدم المرتفع، التدخين، ارتفاع سكر الدم، ارتفاع الكولستيرول، زيادة الوزن والبدانة).</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم وصف هذا الدواء لك كجزء من نظام علاج طبي محدد. يجب عدم استخدامه بواسطة آخرين أو لعلاج أي أعراض أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>انكسار الإبرة</u></p><p dir="RTL">الإبرة المستخدمة لاستعمال كافيرجيكت رفيعة جدًا. ومثل جميع الإبر الرفيعة جدًا، يمكن أن تنكسر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم الإبلاغ عن حالات من انكسار الإبرة، مع بقاء جزء من الإبرة في القضيب. وفي بعض الحالات، كان الحجز بالمستشفى وإجراء عملية لإزالة الإبرة ضروريًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إن التعليمات المحددة حول أساليب التعامل والحقن الصحيحة يمكن أن تقلل من خطر انكسار الإبرة (انظر أيضًا القسم ٣، &quot;كيفية استخدام كافيرجيكت&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج خلل الانتصاب الوظيفي: لا تستخدم أدوية أخرى لعلاج خلل الانتصاب الوظيفي (مثل سيلدينافيل) أو أي أدوية أخرى يمكن أن تؤدي إلى حدوث انتصاب (مثل بابافيرين) في نفس وقت استخدام كافيرجيكت، حيث يزيد ذلك من خطر حدوث انتصاب مطول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الخاصة بالجهاز العصبي: المحاكيات الودية (الأدوية التي تحفز أجزاء محددة من الجهاز العصبي) قد تؤدي إلى تقليل تأثير كافيرجيكت.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الخاصة بالجهاز القلبي الوعائي: قد يزيد كافيرجيكت من تأثيرات خافضات ضغط الدم (الأدوية المستخدمة لخفض ضغط الدم المرتفع)، وموسعات الأوعية (الأدوية المستخدمة لتوسيع الأوعية الدموية)، ومثبطات تجلط الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; &nbsp;مضادات التجلط: إذا كنت تتناول مضادات للتجلط (مثبطات لتجمع الصفائح الدموية، مثل وارفارين أو هيبارين)، فقد يزيد خطر النزيف.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">لا توجد آثار معروفة في الخصوبة لديك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير كافيرجيكت على القيادة </strong><strong>واستخدام الآلات</strong></p><p dir="RTL">من المفترض ألا يكون هناك تأثير لألبروستاديل على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات كافيرجيكت</strong></p><p dir="RTL"><strong>يحتوي مذيب </strong><strong>كافيرجيكت</strong> <strong>على كحول بنزيلي</strong> <strong>وصوديوم</strong></p><p dir="RTL">يحتوي هذا الدواء على كحول بنزيلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يتسبب الكحول البنزيلي في حدوث تفاعلات حساسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إن استخدام كميات كبيرة من مسحوق ومذيب كافيرجيكت لتحضير محلول للحقن قد يسبب تراكم الكحول البنزيلي في جسمك مما ينتج عنه زيادة مستويات الأحماض في دمك (يسمى &quot;الحماض الأيضي&quot;). ينبغي للمرضى المصابين بأمراض الكبد أو الكلى الحرص بشكل خاص واستشارة الطبيب أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يرتبط الكحول البنزيلي بخطر الأعراض الجانبية الشديدة بما في ذلك مشاكل التنفس (تسمى &quot;<em>متلازمة</em>&nbsp;اللهاث&quot;) في الأطفال الصغار. ينبغي عدم استخدام مسحوق ومذيب كافيرجيكت لتحضير محلول للحقن مع الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا الدواء على أقل من ١ مليمول (٢٣ ملجم) من الصوديوم في كل جرعة، أي أنه يُعد &quot;خاليًا من الصوديوم&quot; بشكل أساسي.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائمًا على استخدام هذا الدواء تمامًا كما أخبرك طبيبك. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا مما يجب عليك فعله.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيحدد طبيبك كمية كافيرجيكت التي يجب عليك حقنها، وسوف يعتمد ذلك على سبب خلل الانتصاب الوظيفي لديك. لذا، فمن المهم للغاية أن تتبع توصيات طبيبك بدقة.<br />&nbsp;</p><p dir="RTL">سوف يقوم طبيبك بحقنك في أول مرة، وسيشرح لك كيفية القيام بالحقن بنفسك، إذا كان ذلك محددًا في خطة العلاج الخاصة بك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المنتج مخصص للاستخدام لمرة واحدة فقط. وينبغي التخلص بشكل مناسب من المحقنة وأي محلول غير مستخدم (انظر الخطوة ٦ من بروتوكول الحقن أدناه).</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيخبرك طبيبك بالجرعة الأفضل المناسبة لك. عادةً ما تتراوح جرعة البدء بين ١,٢٥ و٢,٥ ميكروجرام. وسيتم بعد ذلك زيادة الجرعة بزيادات تدريجية إلى أن يتم الوصول إلى جرعة تمكنك من الحصول على انتصاب قوي بما يكفي لممارسة النشاط الجنسي، ولكن لا تسبب انتصابًا يدوم أكثر من ساعة. استشر طبيبك إذا تعرضت لانتصاب مطول. يحدث الانتصاب عادةً خلال ١٠ إلى ٣٠ دقيقة بعد الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عادةً ما تتراوح الجرعة المُثلى بين ١,٢٥ ميكروجرام و٢٠ ميكروجرام لكل مرة حقن، ينبغي عدم استعمال أكثر من ٦٠ ميكروجرام في كل مرة حقن. ينبغي عدم استخدام كافيرجيكت أكثر من مرة واحدة يوميًا أو أكثر من ثلاث مرات أسبوعيًا.<br />ينبغي أن تقوم باستشارة طبيبك كل ٣ إلى ٤ أشهر. عند الضرورة أو النصح بذلك، يمكن تعديل الجرعة تدريجيًا، ولكن احرص دائمًا على استشارة طبيبك أولًا.<br />احرص دائمًا على استخدام هذا الدواء تمامًا كما أخبرك طبيبك.<br />وإذا كان لديك أي أسئلة بشأن استخدام هذا الدواء، فاستشر طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تحضير المحلول</p><p dir="RTL">يجب أن يتم تحضير المحلول تحت ظروف معقمة. عند تحضير المحلول، اتبع إرشادات طبيبك واتبع التعليمات أدناه.</p><p dir="RTL">١. اغسل يديك وجففهما بمنشفة نظيفة.</p><p dir="RTL">٢. أزل الغطاء البلاستيكي الذي يغطي سدادة القارورة التي تحتوي على المسحوق. يجب أن تظل السدادة على القارورة دائمًا. قم بتطهير الجزء العلوي للسدادة باستخدام واحدة من المسحتين الكحوليتين، ثم تخلص من المسحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">قم بتطهير السدادة</p><p dir="RTL">&nbsp;</p><p dir="RTL">٣. وفقًا للشكل الموفر به الدواء، استمر كالتالي:</p><p dir="RTL"><br /><u>قارورة مسحوق كافيرجيكت + أمبولة مذيب</u></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; افتح الأمبولة التي تحتوي على المذيب عن طريق الضغط على الجزء الظاهر في الرسم التوضيحي، بحيث يكون الطرف في مواجهتك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">افتح الأمبولة</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ضع الأمبولة المفتوحة على سطح نظيف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; قم بتركيب الإبرة الطويلة (مقاس &lrm;22 G، بوصة ونصف) بطرف المحقنة وانزع عنها الغطاء الواقي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; اسحب المكبس لسحب كل محتويات (١ مل) الأمبولة إلى المحقنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">قم بتركيب الإبرة الطويلة بالمحقنة وانزع الغطاء الواقي.</p><p dir="RTL"><u>&nbsp;</u></p><p dir="RTL">٤. أدخل الإبرة عبر سدادة القارورة المطاطية التي تم تطهيرها بالفعل، وأفرغ كل محتويات المحقنة في القارورة التي تحتوي على المسحوق.</p><p dir="RTL">٥. رج القارورة برفق (دون نزع المحقنة) حتى يذوب المسحوق بالكامل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">أضف المذيب إلى محتويات القارورة ثم قم بالرج حتى يمتزج المذيب بالكامل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أصبح المحلول الآن جاهزًا للحقن. يحتوي المحلول على ٢٠ ميكروجرام من ألبروستاديل لكل مل. لا تضف أي منتجات أخرى للمحلول. من المفترض أن يكون المحلول شفافًا ولا لون له. وإن لم يكن كذلك، فلا تستخدمه. عند تخزين المحلول المُحضر في القارورة الأصلية، فإنه يكون مستقرًا عند (درجتين مئويتين&ndash;٨ درجات مئوية) لمدة ٢٤ ساعة. يجب عدم تجميده.</p><p dir="RTL">&nbsp;</p><p dir="RTL">حقن المحلول بالقضيب (داخل العضو الذكري)</p><p dir="RTL">سوف يتم الحقن الأول على يد طبيبك، والذي سيشرح لك كيفية حقن المنتج بنفسك. اتبع تعليمات الطبيب بدقة عندما تقوم بحقن كافيرجيكت بنفسك. يمكنك اتباع التعليمات التدريجية الظاهرة أدناه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">١. قم بسحب كمية المحلول، التي تم وصفها لك، في المحقنة.</p><p dir="RTL">٢. انزع الإبرة من المحقنة (على أن تظل الإبرة بالقارورة).</p><p dir="RTL">٣. قم بتركيب إبرة الحقن (لإبرة القصيرة، مقاس &lrm;30 G، نصف بوصة) بطرف المحقنة وانزع عنها الغطاء الواقي.</p><p dir="RTL">٤. إذا كانت الإبرة منحنية فلا تستخدمها. لا تحاول تقويم الإبرة المنحنية. انزع الإبرة من المحقنة وتخلص منها وقم بتركيب إبرة حقن جديدة غير مستخدمة ومعقمة بالمحقنة.</p><p dir="RTL">٥. بينما تمسك بالمحقنة بحيث تتجه الإبرة إلى الأعلى، ادفع المكبس تدريجيًا حتى تظهر قطرة على طرف إبرة الحقن. ضع المحقنة على سطح صلب ومستوٍ وتأكد من عدم ملامسة إبرة الحقن لأي شيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br />اسحب المحلول إلى المحقنة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; أخرج أي فقاعات هواء</p><p dir="RTL">&nbsp;</p><p dir="RTL">٦. الحقن نفسه</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; اجلس في وضع مريح.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستخدم اليد اليمنى، فقم بالإمساك بقضيبك باستخدام يدك اليسرى، خلف رأس القضيب مباشرةً. إذا لم تكن مختونًا، فتأكد من سحب قلفتك لأقصى ما يمكن إلى الخلف بعيدًا عن رأس القضيب. أمسك بالقضيب تجاه فخذك الأيسر. على الطبقة الخارجية من القضيب، ستلاحظ منطقة تبرز نحو اليسار عندما تضغط عليها. هذا واحد من الجسمين الكهفيين. وهذا هو المكان الذي ينبغي أن تقوم بحقن المحلول فيه (المناطق المظللة في الرسم التوضيحي).</p><p dir="RTL">&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:640px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL">أوردة &ndash; أعصاب</p><p dir="RTL">أدخل الإبرة بزاوية ٩٠ درجة</p><p dir="RTL">الجسم الكهفي</p><p dir="RTL">الإحليل</p></td></tr></tbody></table><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مناطق الحقن&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;مقطع عرضي للقضيب</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; باستخدام مسحة الكحول الثانية، استخدم يدك اليمنى لتطهير الجلد الذي يغطي الجسم الكهفي حيث ستقوم بحقن المحلول. اتركه ليجف لعدة ثوان.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; باستخدام يدك اليسرى، أبقِ قضيبك ممتدًا أثناء الحقن. وبيدك اليمنى، أدخل الإبرة عبر الجلد بزاوية ٩٠ درجة حتى تصل إلى منطقة الجسم الكهفي. تجنب الأوعية الدموية الموجودة على السطح وأي بنية ظاهرة أخرى.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; احقن محتويات المحقنة بأكملها. وإذا لم تستطع فعل ذلك، فأخرِج الإبرة قليلًا وابدأ مرة أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">أدخل الإبرة واحقن</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; انزع الإبرة واضغط بمسحة التنظيف فوق موضع الحقن. قم بتدليك القضيب للسماح للمنتج بالانتشار.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; ينبغي عليك تغيير موضع الحقن بانتظام، كما شرح لك طبيبك.</p><p dir="RTL">٧. المحلول مخصص للاستخدام لمرة واحدة فقط. فلا تحتفظ بأي محلول متبقٍ. إذا كنت تستخدم قارورة مسحوق كافيرجيكت + الأمبولة، فقم بلف الإبر المستخدمة بحرص قبل التخلص منها مع القارورة والمحقنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من كافيرجيكت </strong></p><p dir="RTL">إذا استخدمت أو تلقيت كمية أكبر من اللازم من كافيرجيكت، فاتصل على الفور بطبيبك أو الصيدلي أو مركز مكافحة السموم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نسيان تناول جرعة كافيرجيكت</strong></p><p dir="RTL">لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التوقف عن تناول كافيرجيكت</strong></p><p dir="RTL">استشر طبيبك دائمًا إذا كنت تفكر في إيقاف العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك المزيد من الأسئلة بشأن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="right" style="width:100%"><tbody><tr><td style="vertical-align:bottom"><p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، قد يسبب هذا الدواء آثارًا جانبية، غير أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">العرض الجانبي الأكثر شيوعًا بعد الحقن هو وجود ألم خفيف إلى متوسط في القضيب، وقد تم الإبلاغ عن حدوثه مرة واحدة على الأقل من قِبل ثلث المرضى تقريبًا.</p><p dir="RTL">ويعتبر تليف القضيب عرضًا جانبيًا شائعًا نوعًا ما أيضًا، وهو ما قد يؤدي إلى الإصابة بالتشوه أو التيبس (التزوي، والعقيدات التليفية، ومرض بيروني).</p><p dir="RTL">قد يحدث ورم دموي في موضع الحقن لدى بعض المرضى، الأمر الذي يرتبط بأسلوب الحقن أكثر من ارتباطه بالدواء نفسه.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد حقن كافيرجيكت، قد يحدث انتصاب يستمر لمدة تتراوح بين ٤ و٦ ساعات؛ ومن النادر للغاية أن يحدث انتصاب يدوم لأكثر من ٦ ساعات. إذا استمر انتصاب لأكثر من ٤ ساعات، فاستشر طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم الإبلاغ عن الأعراض الجانبية التالية:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض</strong> <strong>جانبية شائعة جدًا</strong> (قد تصيب أكثر من شخص واحد من بين كل ١٠ أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; ألم في القضيب</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض</strong> <strong>جانبية شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل ١٠ أشخاص):</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الانتصاب المطول، تشوه أو تيبس القضيب، مشكلات أخرى في القضيب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; احمرار الجلد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الورم الدموي في موضع الحقن، التكدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; التشنجات العضلية (التقلصات)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض</strong> <strong>جانبية غير شائعة</strong> (قد تصيب ما يصل إلى شخص واحد من بين كل ١٠٠ شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; العدوى: العدوى الفطرية، نزلات البرد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء، فقدان الحساسية، زيادة الحساسية، الصداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; اتساع حدقتي العينين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات ضربات القلب (الانقباضات الخارجة فوق البطينية)</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong>مشكلات بالأوردة، انخفاض ضغط الدم، توسع الأوعية الدموية ومشكلات بالأوعية الدموية، النزيف من الأوردة</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong>الغثيان، جفاف الفم</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong>العرق الغزير، الطفح الجلدي، الحكة</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong>ألم في الوركين أو الظهر، ضعف العضلات الألوية، ألم في الأرداف أو الساقين أو البطن</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp; </strong>صعوبة التبول، وجود دم بالبول، زيادة معدل التبول، إلحاح التبول مع السلس، نزيف من الإحليل (القناة التي يمر خلالها البول عبر القضيب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات بالانتصاب، اضطرابات القذف، التهاب رأس القضيب (التهاب الحشفة)، انتصاب مؤلم، الشبم (تضيق القلفة)، القساح (الانتصاب المطول)، ألم في الخصيتين، اضطرابات الصفن (الجراب الجلدي الذي يحتوي على الخصيتين)، احمرار الصفن، ألم في الصفن، احتباس السوائل في الصفن (تورم)، تكيس حميد (قيلة منوية) في القناة التي تحمل السائل المنوي خارجًا من الخصيتين، اضطرابات الخصيتين، تورم الخصيتين، احتباس السوائل في الخصيتين، تكون كتل على الخصيتين، ألم في أسفل البطن (منطقة الحوض)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الضعف العام، النزيف، الالتهاب، التورم الطرفي (احتباس السوائل الذي يؤثر على الوجه والأطراف، وخاصةً الساقين)، التورم، الألم أو الشعور بالضغط، متلازمة شبيهة بالأنفلونزا</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مشكلات في موضع الحقن: النزيف، الالتهاب، الحكة، الورم، التورم، الشعور بالدفء، التهيج، فقدان الإحساس (الخدر)، الألم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم، زيادة معدل ضربات القلب، زيادة كمية الكرياتينين بالدم (تتم ملاحظتها أثناء فحص الدم)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معدل التكرار غير معروف</strong> (لا يمكن تقديره من البيانات المتاحة):</p><ul><li dir="RTL">نقص تدفق الدم إلى عضلة القلب من خلال الشرايين التاجية</li><li dir="RTL">السكتة الدماغية</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية </strong></p><p dir="RTL">إذا تعرضت لأي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي. يشمل ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً عبر نظام الإبلاغ القومي. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">للإبلاغ عن الآثار الجانبية:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:385px"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>المركز الوطني للتيقظ الدوائي:</strong></p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال الموحد: ١٩٩٩٩</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الالكتروني: <u>https://ade.sfda.gov.sa/ </u>&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>دول الخليج الأخرى:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp; الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احتفظ بهذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL"><em><u>&nbsp;</u></em></p><p dir="RTL">خزنه في درجة حرارة أقل من ٣٠ درجة مئوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء<em> </em>بعد تاريخ انتهاء الصلاحية المدون على العبوة الكرتونية بعد رمز &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">صلاحية المستحضر: ٣ أعوام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف أو مع النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي ألبروستاديل:</p><p dir="RTL">تحتوي كل قارورة مسحوق على ٢٠ ميكروجرام من ألبروستاديل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي:</p><p dir="RTL">- المسحوق: لاكتوز أحادي الهيدرات، سترات الصوديوم، حمض هيدروكلوريك مخفف، هيدروكسيد الصوديوم.</p><p dir="RTL">- المذيب: كحول بنزيلي، (انظر القسم ٢ &quot;يحتوي مذيب كافيرجيكت على كحول بنزيلي وصوديوم&quot;) ماء للحقن.</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">محلول للحقن، يتم الحصول عليه من خلط المسحوق بالمذيب، وكلاهما مرفقان بالعبوة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أحجام العبوات:</p><p dir="RTL">كافيرجيكت ٢٠ ميكروجرام، مسحوق ومذيب لتحضير محلول للحقن: قارورة مسحوق واحدة + أمبولة واحدة تحتوي على ١ مل من المذيب</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>مالك تصريح التسويق: </em></p><p dir="RTL">Pfizer SA, Belgium، بلجيكا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الجهة المصنعة: </em></p><p dir="RTL">Pfizer Manufacturing Belgium NV, Belgium، بلجيكا.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            : أكتوبر ٢٠٢٣.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CAVERJECT 20 micrograms powder and solvent for solution for injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                CAVERJECT 20 micrograms: each vial contains 20 micrograms Alprostadil.

Excipient with known effect:
The solvent contains benzyl alcohol.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder and solvent for solution for injection.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed etiology.</p><p>Useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.</p><p><strong>&nbsp;</strong></p><p>CAVERJECT is not indicated for paediatric use (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p><u>&nbsp;</u></p><p>Based on the possible complications of intracavernous injection of vaso-active drugs, it is recommended that the diagnosis and the initial dose should be determined by a physician-specialist.</p><p>&nbsp;</p><p>CAVERJECT TO THE DIAGNOSIS OF ERECTILE DYSFUNCTION</p><p>After an intracavernous injection of CAVERJECT, the occurrence of an erection is monitored.</p><p>To allow assessment of penile vasculature, CAVERJECT can be used as an adjunct to laboratory investigations such as duplex or Doppler imaging, Xenon washout tests, radioisotope penogram and penile arteriography.</p><p>For any of these tests, a single dose of CAVERJECT that induces an erection with firm rigidity should be used.</p><p>&nbsp;</p><p>INITIAL TITRATION IN PHYSICIAN&rsquo;S OFFICE</p><p>The first injection of CAVERJECT must be done at the physician&#39;s office by medically trained personnel.</p><p>The patient must stay in the physician&rsquo;s office until complete detumescence occurs. During titration no more than two doses should be given within a 24-hour period. If there is a partial response, then there should be at least a 1-day interval before the next dose is given. If there is no response, it is also advisable to wait at least 1 day.</p><p>&nbsp;</p><p><u>Erectile dysfunction of vasculogenic, psychogenic or mixed etiology. </u></p><p>Dosage titration should be initiated at 2.5 micrograms of alprostadil. If there is only a partial response, the dose may be increased to a dose of 5 micrograms and then in increments of 5 to 10 micrograms, until an erection suitable for intercourse is produced. It is recommended that the administered dose produces a duration of the erection not exceeding one hour. The patient must stay in the physician&rsquo;s office until complete detumescence occurs.</p><p>If there is no response to the initial 2.5 micrograms dose, the second dose may be increased to 7.5 micrograms, followed by increments of 5 to 10 micrograms. If there is a partial response, then there should be at least a 1-day interval before the next dose is given. If there is no response, it is also advisable to wait at least 1 day.</p><p>&nbsp;</p><p><u>Erectile dysfunction of neurogenic etiology (Spinal Cord Injury)</u></p><p>Dosage titration should be initiated at 1.25 micrograms of alprostadil. The dose may be increased by 1.25 micrograms to a dose of 2.5 micrograms, followed by an increment of 2.5 micrograms to a dose of 5 micrograms, and then in 5 micrograms increment until an erection suitable for intercourse is produced. It is recommended that the administered dose produces a duration of the erection not exceeding one hour. The patient must stay in the physician&rsquo;s office until complete detumescence occurs. If there is a partial response, then there should be at least a 1-day interval before the next dose is given. If there is no response, it is also advisable to wait at least 1 day.</p><p><u>&nbsp;</u></p><p>The following table gives an overview of the dosage schedule in relation to the etiology :</p><table border="0" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Neurogenic etiology (Spinal Cord Injury)</strong></p></td><td style="vertical-align:top"><p><strong>Vasculogenic, psychogenic or mixed etiology</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;Starting dose</strong></p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1;25 micrograms</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 micrograms</p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;Second dose</strong></p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.5 &nbsp;micrograms</p></td><td style="vertical-align:top"><p>Partial response: 5 micrograms</p><p>No response: 7.5 micrograms</p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;Third dose</strong></p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.0 &nbsp;micrograms</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;Further</strong></p><p><strong>&nbsp;dose titration</strong></p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.0 &nbsp;micrograms</p></td><td style="vertical-align:top"><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5 to 10 micrograms</p></td></tr></tbody></table><p>&nbsp;</p><p>In clinical studies, patients were treated with CAVERJECT in doses ranging from 0.2 to 140 micrograms. More than 80% of the treated patients experienced an erection sufficient for sexual intercourse.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>CAVERJECT must not be used in the paediatric population (see section 4.3 Contraindications and 4.4 Special warning and precautions to use, benzyl alcohol).</p><p>&nbsp;</p><p><u>Method of administration </u></p><p>&nbsp;</p><p>MAINTENANCE THERAPY</p><p>Self-injection therapy by the patient can be started only after the patient is properly instructed and well trained in the self-injection technique. The intracavernous injection must be done under sterile conditions.</p><p>The dose of CAVERJECT that is selected for self-injection treatment should provide the patient with an erection that is satisfactory for sexual intercourse it is recommended that the administered dose produces a duration of the erection not exceeding one hour. If the duration of erection is longer than 1 hour, the CAVERJECT dose should be reduced. Self-injection therapy for use at home should be initiated at the dose that was determined by the physician. In general, the lowest possible effective dose should be employed. However, the physician should consider the wishes of the individual patient when defining the dose for self-injection. If required, and only after consultation with the physician, the dose may be adjusted in accordance with the titration guidelines described above. Careful and continuous follow-up of the patient while in the self-injection program must be exercised, especially during the initial self-injections, since adjustments in the CAVERJECT dose may be needed. Since 99% of patients received doses of maximum 60 micrograms, doses of greater than 60 micrograms are not recommended.</p><p>The recommended frequency of injection is no more than once daily and no more than three times weekly. The reconstituted vial of CAVERJECT is intended for single use only and should be discarded after use. The user should be instructed in the safe disposal of the injection syringe, injection needles and vial. While on self-injection treatment, the patient should visit the prescribing physician&#39;s office every 3-4 months. At that time, the efficacy and safety of the therapy should be assessed, and the dose of CAVERJECT should be adjusted, if needed. This was the case for up to 57% of patients in one clinical study. The effectiveness of CAVERJECT for long-term use has been documented in an uncontrolled, self-injection study. The mean dose of CAVERJECT at the end of 6 months was about 20 micrograms.</p><p>&nbsp;</p><p>PREPARATION OF THE SOLUTION</p><p>The lyophilized powder is packaged in a 5ml vial.</p><p>The enclosed bacteriostatic water for injection (benzyl alcohol) of 1 ml must be added to the vial. After reconstitution by addition of 1 ml of bacteriostatic water for injection, the resulting solution will contain 20 micrograms per milliliter of alprostadil, 172 milligrams per ml of lactose, and 47 micrograms per ml of sodium citrate. Once reconstituted, no additional materials should be injected into the vial. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration.</p><p><strong>&nbsp;</strong></p><p>INJECTION OF THE SOLUTION IN THE PENIS</p><p>CAVERJECT is administered by direct intracavernous injection. A 27 to 30 Gauge 1/2 inch injection needle is recommended.</p><p>The site of injection is usually along the dorso-lateral aspect of the proximal third of the penis. The injection site must be cleansed with an alcohol swab. It is recommended to regularly alter the side of the penis that is injected. Injecting in visible veins should be avoided.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Intracavernous alprostadil should not be used:
	in patients who have an hypersensitivity to the active substance or to any of the excipients listed in section 6.1
	in patients prone to priapism due to sickle cell anaemia or latent sickle cell disease (without anaemia), multiple myeloma or leukaemia
	in patients with anatomical deformation of the penis, such as angulation, phimosis, cavernosal fibrosis, or Peyronie's disease.
	in patients with penile implants
	in men for whom sexual activity is inadvisable or contraindicated
	in premature babies or neonates (see section 4.4) and children.  


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Underlying treatable medical causes of erectile dysfunction should be diagnosed and treated prior to initiation of therapy with alprostadil.</p><p>&nbsp;</p><p><u>Priapism</u></p><p>Prolonged erection and/or priapism (erection lasting over six hours) are known to occur following intracavernous administration of vasoactive substances, including alprostadil. In order to minimise this risk, the lowest effective dose should be selected; patients should be instructed to immediately report to a physician any erection lasting for an overly prolonged time period, such as 4 hours or longer. Treatment of priapism should not be delayed more than 6 hours (see section 4.9).&nbsp; The treatment of priapism should be according to established medical practice. The treatment of priapism may include different approaches such as aspiration, intracavernous injection of sympathomimetic amines or surgery. In evaluating a patient for alprostadil therapy, the physician should determine which of these interventions would be appropriate for the individual patient.</p><p>&nbsp;</p><p><u>Penile fibrosis</u></p><p>Painful erection is more likely to occur in patients with anatomical deformations of the penis, such as angulation, phimosis, cavernosal fibrosis, Peyronie&rsquo;s disease or plaques.</p><p>Penile fibrosis, including angulation, cavernosal fibrosis, fibrotic nodules and Peyronie&#39;s disease may occur following the intracavernous administration of alprostadil. Fibrosis may occur more frequently with prolonged use.</p><p>&nbsp;</p><p>Regular controls and careful examination of the penis are highly recommended to detect early signs of fibrosis or Peyronie&#39;s disease.</p><p>&nbsp;</p><p>Treatment with CAVERJECT should be discontinued in patients who develop penile angulation, cavernosal fibrosis, or Peyronie&rsquo;s disease.</p><p>&nbsp;</p><p><u>Sexually transmitted and blood borne diseases, including HIV</u></p><p>Use of intracavernous alprostadil offers no protection from the transmission of sexually transmitted diseases. Individuals who use alprostadil should be counselled about the protective measures that are necessary to guard against the spread of sexually transmitted diseases, including the human immunodeficiency virus (HIV). Injection of CAVERJECT can induce a small amount of bleeding at the site of injection (see Undesirable effects), which could increase transmission of such diseases.</p><p>&nbsp;</p><p><u>Anticoagulants</u></p><p>Patients on anticoagulants, such as warfarin or heparin, may have an increased risk of bleeding after intracavernous injection.</p><p>&nbsp;</p><p>CAVERJECT should be used with caution in patients with cardiovascular and cerebrovascular risk factors.</p><p>&nbsp;</p><p>Alprostadil should be used with caution in patients who have experienced transient ischaemic attacks or those with unstable cardiovascular disorders.</p><p>&nbsp;</p><p>Sexual stimulation and intercourse can lead to cardiac and pulmonary events in patients with coronary heart disease, congestive heart failure or pulmonary disease. &nbsp;These patients when using alprostadil should engage in sexual activity with caution.</p><p>&nbsp;</p><p>Alprostadil is not intended for co-administration with any other agent for the treatment of erectile dysfunction (see also 4.5).</p><p>&nbsp;</p><p>The potential for abuse of alprostadil should be considered in patients with a history of psychiatric disorder or addiction.</p><p>&nbsp;</p><p>Reconstituted solutions of alprostadil are intended for single use only. &nbsp;The injection delivery system/syringe and any remaining solution should be properly discarded.</p><p>&nbsp;</p><p><u>Needle breakage</u></p><p>CAVERJECT uses a superfine needle for administration. As with all superfine needles, the possibility of needle breakage exists.</p><p>&nbsp;</p><p>Needle breakage, with a portion of the needle remaining in the penis, has been reported and, in some cases, required hospitalization and surgical removal.</p><p>&nbsp;</p><p>Careful patient instruction in proper handling and injection techniques may minimize the potential for needle breakage.</p><p>&nbsp;</p><p>The patient should be instructed that, if the needle is bent, it must not be used; they should also not attempt to straighten a bent needle.&nbsp; They should remove the needle from the syringe, discard it, and attach a new, unused sterile needle to the syringe.</p><p>&nbsp;</p><p><u>Excipient information</u></p><p>&nbsp;</p><p><em>Benzyl alcohol</em></p><p>The solvent contains benzyl alcohol. Benzyl alcohol may cause allergic reactions.</p><p>&nbsp;</p><p>The combined daily metabolic load of benzyl alcohol from all sources should be considered, as high volumes should be used with caution and only if necessary, especially in patients with liver or kidney impairment because of the risk of accumulation and toxicity (metabolic acidosis).</p><p>&nbsp;</p><p>This medicine is only indicated for intracavernosal injection. Intravenous administration of the preservative benzyl alcohol has been associated with serious adverse events and death in paediatric patients including neonates (&ldquo;gasping syndrome&rdquo;). The minimum amount of benzyl alcohol at which toxicity may occur is not known. Premature and low-birth weight infants may be more likely to develop toxicity. CAVERJECT powder and solvent for solution for injection is not indicated for paediatric use.</p><p>&nbsp;</p><p><em>Sodium</em></p><p>This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Potential pharmacokinetic drug interactions between CAVERJECT and other substances have not been formally studied. In clinical studies concurrent use of diuretics, antidiabetic agents (including insulin) or non-steroid anti-inflammatory agents did not have any effect on the safety or efficacy of CAVERJECT.</p><p>&nbsp;</p><p>The effects of combinations of alprostadil with other treatments for erectile dysfunction (e.g. sildenafil) or other drugs inducing erection (e.g. papaverine) have not been formally studied. Such agents should not be used in combination with alprostadil due to the potential for inducing prolonged erections.</p><p>&nbsp;</p><p>Sympathomimetics may reduce the effect of alprostadil. Alprostadil may enhance the effects of antihypertensives, vasodilative agents, anticoagulants and platelet aggregation inhibitors.</p><p>Patients on anticoagulants such as warfarin or heparin may have increased propensity for bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy and lactation</u></p><p>Not applicable</p><p><em>&nbsp;</em></p><p><u>Fertility</u></p><p>In a study in male rats, alprostadil had no effect on reproductive function (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Alprostadil would not be expected to have an influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most frequent adverse effects following an intracavernous injection was pain in the penis. 30% of patients reported pain at least once. Pain was associated with 11% of the injections administered. In most cases pain was assessed as mild or moderate. 3% of patients discontinued treatment because of pain.</p><p>&nbsp;</p><p>Penile fibrosis, including angulation, fibrotic nodules and Peyronie&rsquo;s disease, was reported in 3% of clinical trial patients overall. In one self-injection study in which the duration of use was up to 18 months, the incidence of penile fibrosis was higher, approximately 8%.</p><p>&nbsp;</p><p>Haematoma and ecchymosis at the injection site, which is related with the injection technique rather than the effect of alprostadil, was reported by 3% and 2% of patients, respectively.</p><p>&nbsp;</p><p>Prolonged erection (an erection for 4-6 hours) developed in 4% of patients. Priapism (a painful erection for more than 6 hours) occurred in 0.4%. In most cases it disappeared spontaneously.</p><p>&nbsp;</p><p>Adverse drug reactions reported during clinical trials and post marketing experience are presented in the table below, frequencies are very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); not known (cannot be estimated from the available data).&nbsp; The adverse drug reactions are listed in order of decreasing medical seriousness within each frequency category and system organ class.</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Very common </strong></p><p><strong>(&ge;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Common </strong></p><p><strong>(&ge;1/100 to &lt;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon </strong></p><p><strong>(&ge;1/1,000 to &lt;1/100)</strong></p></td><td style="vertical-align:top"><p><strong>Not known </strong></p><p><strong>(cannot be estimated from the available data)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Fungal infection, Common cold</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Presyncope, Hypoaesthesia, Hyperaesthesia, Headache</p></td><td style="vertical-align:top"><p>Cerebrovascular accident</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Mydriasis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Supraventricular extrasystoles</p></td><td style="vertical-align:top"><p>Myocardial ischaemia</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Haematoma</p></td><td style="vertical-align:top"><p>Venous haemorrhage, Hypotension*, Vasodilatation, Peripheral vascular disorder, Vein disorder</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Nausea, Dry mouth</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Erythema</p></td><td style="vertical-align:top"><p>Rash, Hyperhidrosis, Pruritus</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Muscle spasms</p></td><td style="vertical-align:top"><p>Pain in the hip and back, Weakness in the muscles of the thigh, Pain in the thighs, legs, and in the abdomen</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Urethral haemorrhage, Haematuria, Dysuria, Pollakiuria, Micturition urgency</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Penile Pain</p></td><td style="vertical-align:top"><p>Peyronie&rsquo;s disease, Penis disorder, Erection increased</p></td><td style="vertical-align:top"><p>Priapism, Pelvic pain, Testicular mass, Spermatocele, Testicular swelling, Testicular oedema, Testicular disorder, Scrotal pain, Scrotal erythema, Scrotal oedema,&nbsp; Testicular pain, Scrotal disorder, Painful erection, Balanitis, Phimosis, Erectile dysfunction, Ejaculation disorder</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Injection site haematoma, Haematoma, Ecchymosis</p></td><td style="vertical-align:top"><p>Haemorrhage, Injection site haemorrhage, Inflammation, Injection site inflammation, Injection site warmth, Injection site oedema, Injection site swelling, Injection site pain, Injection site irritation, Asthenia, Injection site anaesthesia, Oedema, Oedema peripheral, Injection site pruritus, Pain or tightness, Flu-syndrome</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Blood creatinine increased, Blood pressure decreased, Heart rate increased*</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>* Dose-dependent haemodynamic changes were observed such as drop in blood pressure and rapid heart beat, with doses exceeding 20 or 30 micrograms respectively. These changes were usually not clinically significant: only 3 out of the 1712 patients in the clinical studies discontinued treatment because of symptomatic hypotension.</p><p>&nbsp;</p><p>In some patients the systemic effects are more likely to be due to the injection procedure than to the pharmacological properties of alprostadil. The results of serum and urine analyses were not affected by the use of CAVERJECT.</p><p><u>&nbsp;</u></p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local country requirements.</p><p>&nbsp;</p><p>To report side effects:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>The National Pharmacovigilance Centre (NPC)</p>&nbsp;<p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa/ &nbsp;</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other </strong><strong>GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Overdosage was not observed in clinical trials with alprostadil. If intracavernous overdose of CAVERJECT occurs, the patient should be placed under medical supervision until any systemic effects have resolved and/or until penile detumescence has occurred. Symptomatic treatment of any systemic symptoms would be appropriate.&nbsp;</p><p>In man, prolonged erection and/or priapism are known to occur following intracavernous administration of vasoactive substances, including alprostadil. The treatment of priapism should be according to established medical practice. The treatment of priapism may include different approaches such as aspiration, intracavernous injection of sympathomimetic amines or surgery. When evaluating the patient before alprostadil therapy, the physician will determine what kind of intervention is most suitable for the individual patient. Patients should be instructed to report to a physician any erection lasting for a prolonged time period, such as 4 hours or longer.</p><p>&nbsp;</p><p>The treatment of priapism (prolonged erection) should not be delayed more than 6 hours. Initial therapy should be by penile aspiration. Using aseptic technique, insert a 19‑21 gauge butterfly needle into the corpus cavernosum and aspirate 20‑50 ml of blood. This may detumesce the penis. If necessary, the procedure may be repeated on the opposite side of the penis until a total of up to 100 ml blood has been aspirated. If still unsuccessful, intracavernous injection of alpha‑adrenergic medication is recommended. Although the usual contra‑indication to intrapenile administration of a vasoconstrictor does not apply in the treatment of priapism, caution is advised when this option is exercised. Blood pressure and pulse should be continuously monitored during the procedure. Extreme caution is required in patients with coronary heart disease, uncontrolled hypertension, cerebral ischaemia, and in subjects taking monoamine oxidase inhibitors.&nbsp; In the latter case, facilities should be available to manage a hypertensive crisis. A 200 microgram/ml solution of phenylephrine should be prepared, and 0.5 to 1.0 ml of the solution injected every 5 to 10 minutes.&nbsp; Alternatively, a 20 microgram/ml solution of epinephrine should be used. If necessary, this may be followed by further aspiration of blood through the same butterfly needle. The maximum dose of phenylephrine should be 1 mg, or epinephrine 100 micrograms (5 ml of the solution). As an alternative metaraminol may be used, but it should be noted that fatal hypertensive crises have been reported.&nbsp; If this still fails to resolve the priapism, urgent surgical referral for further management, which may include a shunt procedure is required.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Drugs used in erectile dysfunction</p><p>ATC code: G04BE01</p><p>&nbsp;</p><p>Alprostadil or prostaglandin E1 is one of a family of naturally-occurring acidic lipids. Vasodilation and inhibition of platelet aggregation are among the most notable pharmacological effects. Alprostadil, when given by intracavernous injection, induces erection in men. The erection usually starts within 10-30 minutes after injection. The duration of erection is dose-dependent. Alprostadil induces erection by relaxation of trabecular smooth muscle and by dilation of cavernosal arteries. This leads to expansion of lacunar spaces and entrapment of blood by compressing venules against the tunica albuginea.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetics of intravenously administered alprostadil have been extensively studied. When administered intravenously to man, alprostadil is rapidly transformed to relatively inactive metabolites. In healthy men 70% to 90% of alprostadil is extensively extracted and metabolized in a single pass through the lungs, resulting in a metabolic half-life of less than one minute. After intracavernous administration, levels of alprostadil and its primary metabolite 15-oxo-13,14-dihydro-PGE1 are elevated in the corpora cavernosa. No intact alprostadil is detected in the peripheral circulation, and levels of the 15-oxo-13,14-dihydro-PGE1 metabolite are here not significantly elevated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Long term carcinogenicity studies have not been conducted. A standard battery of genotoxicity studies revealed no mutagenic potential of alprostadil.</p><p>&nbsp;</p><p>Alprostadil at subcutaneous doses of up to 0.2 mg/kg/day (200 times the maximum recommended human intracavernous dose) had no adverse effects on reproductive function in male rats.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>CAVERJECT lyophilized powder: lactose monohydrate, sodium citrate, dilute hydrochloric acid, sodium hydroxide.</p><p>Solvent: benzyl alcohol, water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No known incompatibilities. CAVERJECT is not intended for simultaneous injection with any other agent for the treatment of erectile dysfunction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Do not use Caverject after the expiry date which is stated on the carton after EXP:. 
Shelf life: 3 years.

The expiry date (month/year) is mentioned on the package after "EXP:" (EXP = expiry date).
When stored in the original container, the reconstituted alprostadil solution is physically and chemically stable for a period of 24 hours at (2°C - 8°C). Reconstituted solutions should not be frozen.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>CAVERJECT 20 micrograms powder and solvent for solution for injection:</p><p>1 vial with powder + 1 ampoule with 1 ml solvent</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p>No special requirements for disposal.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
MARKETING AUTHORISATION HOLDER
Pfizer SA, Belgium.

MANUFACUTRED BY
Pfizer Manufacturing Belgium NV, Belgium

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                October 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>